AMICUS THERAPEUTICS INC (FOLD:NASDAQ)
$14.47 0 (0%)
Analysed AMICUS THERAPEUTICS INC (FOLD:NASDAQ) News Sources
Here is Why BioMarin (BMRN) is Projected to Rally
31-03-2026
yahoo.com
Assessing Amicus Therapeutics (FOLD) Valuation After A Strong 71% One Year Total Return
29-03-2026
yahoo.com
Why Is Adma Biologics (ADMA) Down 45.4% Since Last Earnings Report?
27-03-2026
yahoo.com
Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating
26-03-2026
yahoo.com
Iovance Biotherapeutics (IOVA) Down 2.1% Since Last Earnings Report: Can It Rebound?
26-03-2026
yahoo.com
BioMarin (BMRN) Down 13.6% Since Last Earnings Report: Can It Rebound?
25-03-2026
yahoo.com
Assessing Amicus Therapeutics (FOLD) Valuation After Recent Share Price Momentum And DCF Upside
15-03-2026
yahoo.com
Viking Therapeutics Stock Gets RS Rating Upgrade
10-03-2026
yahoo.com
Rice Hall James Loads Up on BIRK With 466,000 Shares Bought
09-03-2026
fool.com
Rice Hall James Buys QuidelOrtho Stock
09-03-2026
fool.com
What is the current price of AMICUS THERAPEUTICS INC (FOLD:NASDAQ)?
The current price of AMICUS THERAPEUTICS INC (FOLD:NASDAQ) is $14.47.
AMICUS THERAPEUTICS INC (FOLD:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMICUS THERAPEUTICS INC (FOLD:NASDAQ) since the previous trading day is $0.
AMICUS THERAPEUTICS INC (FOLD:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMICUS THERAPEUTICS INC (FOLD:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for AMICUS THERAPEUTICS INC (FOLD:NASDAQ)?
The most recent average sentiment score for AMICUS THERAPEUTICS INC (FOLD:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for AMICUS THERAPEUTICS INC (FOLD:NASDAQ)?
The most recent sentiment for AMICUS THERAPEUTICS INC (FOLD:NASDAQ) is .
SEC-8K** Filing Available For AMICUS THERAPEUTICS INC (FOLD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.